The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors
Open Access
- 14 June 2020
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 10 (2)
Abstract
Background: Estrogen receptor (ER) is essential in reproductive development and is also the primary driver of breast cancers. Deregulation of ER may also be involved in tumorigenesis of other organs. To understand the role of ER in different tumor types, pan‐cancer analysis of estrogen receptor alpha (ESR1) and estrogen receptor beta (ESR2) in various tumors and association with patients' survival were conducted using The Cancer Genome Atlas (TCGA) data.Results: Gene methylation level was evaluated by the mean methylation level of CpG sites in the promoter region. The significant different DNA methylation between tumor and healthy tissues was shown in 10 tumor types for ESR1 and eight tumor types for ESR2. The methylation pattern was also varied across different TCGA tumors. The pan‐cancer analysis showed significantly different mRNA expression of ESR1 in nine tumor types and ESR2 in four tumor types. Survival analysis showed that the effects of ERs expression on survival are diverse in different tumors. The expression of ERs was associated with tumor molecular subtypes and various clinical characteristics. ER correlated genes were mainly enriched in cancer and immune‐related pathways.Conclusions: Our pan‐cancer analysis data indicated that ERs might be significantly associated with carcinogenesis and progression of some tumors, which may be potential therapeutic targets and prognosis biomarkers.Keywords
Funding Information
- National Young 1000 Talents Program
- Jiangsu Province Education Department Grant
- Jiangsu Province “Innovative and Entrepreneurial Team” and “Innovative and Entrepreneurial Talent” Grant
- Chinese Society of Clinical Oncology Research Foundation
- Southeast University-Nanjing Medical University Cooperative Research Project
- Key Research and Promotion Projects of Henan Province (NO.202102310094)
- Wu Jieping Medical Foundation of Clinical Research Special Fund (NO.320.2710.1836)
- Funding of "Peak" Training Program for Scientific Research of Yijishan Hospital
- Wannan Medical College (No.GF2019G19)
This publication has 46 references indexed in Scilit:
- Estrogen receptor signaling during vertebrate developmentBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2015
- Integrated Genomic Characterization of Papillary Thyroid CarcinomaCell, 2014
- The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivoBreast Cancer Research, 2014
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancerNature Genetics, 2013
- DNA Methylation of the SLC16A3 Promoter Regulates Expression of the Human Lactate Transporter MCT4 in Renal Cancer with Consequences for Clinical OutcomeClinical Cancer Research, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialAnnals of Oncology, 2011
- The G-protein-coupled estrogen receptor GPER in health and diseaseNature Reviews Endocrinology, 2011
- Steroid hormone receptors in cancer development: A target for cancer therapeuticsCancer Letters, 2011
- Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancerNature Genetics, 2007